AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Neville, C Whalley, D McKenna, S Le Comte, M Fortin, PR
Citation: C. Neville et al., Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada, J RHEUMATOL, 28(7), 2001, pp. 1505-1510

Authors: Tsao, LN Neville, C Musaro, A McCullagh, KJA Rosenthal, N
Citation: Ln. Tsao et al., Revisiting calcineurin and human heart failure, NAT MED, 6(1), 2000, pp. 2-3

Authors: Fortin, PR Abrahamowicz, M Clarke, AE Neville, C Du Berger, R Fraenkel, L Liang, MIH
Citation: Pr. Fortin et al., Do lupus disease activity measures detect clinically important change?, J RHEUMATOL, 27(6), 2000, pp. 1421-1428

Authors: Neville, C Clarke, AE Joseph, L Belisle, P Ferland, D Fortin, PR
Citation: C. Neville et al., Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity, J RHEUMATOL, 27(3), 2000, pp. 675-679

Authors: Lucey, MD Newkirk, MM Neville, C Lepage, K Fortin, PR
Citation: Md. Lucey et al., Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis, J RHEUMATOL, 27(2), 2000, pp. 319-323

Authors: Yen, JC Neville, C Fortin, PR
Citation: Jc. Yen et al., Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials, LUPUS, 8(8), 1999, pp. 660-670

Authors: Neville, C Fortin, PR Fitzcharles, MA Baron, M Abrahamowitz, M Du Berger, R Esdaile, JM
Citation: C. Neville et al., The needs of patients with arthritis: The patient's perspective, ARTH C RES, 12(2), 1999, pp. 85-95

Authors: Moore, AD Clarke, AE Danoff, DS Joseph, L Belisle, P Neville, C Fortin, PR
Citation: Ad. Moore et al., Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices, J RHEUMATOL, 26(6), 1999, pp. 1285-1290

Authors: Newkirk, MM Apostolakos, P Neville, C Fortin, PR
Citation: Mm. Newkirk et al., Systemic lupus erythematosus, a disease associated with low levels of clusterin/ApoJ, an antiinflammatory protein, J RHEUMATOL, 26(3), 1999, pp. 597-603

Authors: Hebert, RL O'Connor, T Neville, C Burns, KD Laneuville, O Peterson, LN
Citation: Rl. Hebert et al., Prostanoid signaling, localization, and expression of IP receptors in rat thick ascending limb cells, AM J P-REN, 44(6), 1998, pp. F904-F914

Authors: Rauch, J Tannenbaum, M Neville, C Fortin, PR
Citation: J. Rauch et al., Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin, THROMB HAEM, 80(6), 1998, pp. 936-941
Risultati: 1-11 |